Media Coverage

At 5.7 percent Louisiana’s drug test positivity rate is over 1 percent higher than the national average, according to a map produced by Quest Diagnostics' drug testing index.

Quest Diagnostics Inc (NYSE:DGX) institutional sentiment increased to 0.93 in Q2 2018. Its up 0.13, from 0.8 in 2018Q1. The ratio has increased, as 217 funds opened new and increased equity positions, while 234 cut down and sold their stakes in Quest Diagnostics Inc. The funds in our partner’s database reported: 110.90 million shares, down from 111.81 million shares in 2018Q1. Also, the number of funds holding Quest Diagnostics Inc in their top 10 equity positions increased from 0 to 3 for an increase of 3. Sold All: 30 Reduced: 204 Increased: 145 New Position: 72.

Dana-Farber Cancer Institute scientists will present research marking significant advances against the hematologic cancer multiple myeloma at the American Society of Hematology (ASH) Annual Meeting Dec. 1-4. Their findings provide new insights into the progression of the disease from precursor conditions and suggest approaches for novel treatments. Testing will be performed at each participant's local Quest Diagnostics laboratory. To sign up for the study, please visit http://www.promisestudy.org.

Aetna, a CVS Health business, and Ascension have joined the pilot project applying blockchain technology to improve data quality and reduce administrative costs associated with changes to health care provider demographic data. Humana, MultiPlan, Quest Diagnostics and UnitedHealth Group’s (NYSE: UNH) Optum and UnitedHealthcare announced the launch of the Synaptic Health Alliance pilot project in April.

Quest Diagnostics made it official: It is coming to the city and bringing 1,100 jobs. The company told officials it hopes to break ground for the 250,000-square-foot facility and accompanying five to seven-story parking garage this spring, officials said.